Immunome Ownership & Insider Activity

Immunome (IMNM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.5% of shares outstanding. Institutional investors hold 79.5%. Over the past 90 days, insiders made 3 sales worth $3.4M.

Shares Outstanding

118.003M

Shares Float

101.562M

Insider Shares Owned

3.941M

Insider % Owned

3.5%

Institutional Shares Held

90.260M

Institutional % Held

79.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$3.4M total

Net Activity

Net Selling

Net Value (90d)

-$3.4M

Immunome Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 11, 2026	Jack Higgins	CHIEF SCIENTIFIC OFFICER	SELL	4.000K	$13.34	$310K
Aug 10, 2026	Isaac Barchas	—	SELL	83.464K	$26.35	$2.2M
Aug 6, 2026	Isaac Barchas	—	SELL	36.088K	$26.06	$940K
Aug 4, 2026	Kinney Horn	CHIEF BUSINESS OFFICER	SELL-OPTIONS	—	$18.49	$1.2M
Jul 7, 2026	Kinney Horn	CHIEF BUSINESS OFFICER	SELL-OPTIONS	—	$18.96	$13K
Jul 6, 2026	Isaac Barchas	—	SELL	100.000K	$24.13	$2.4M
Jul 2, 2026	Robert Lechleider	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$15.68	$764K
Jun 30, 2026	Isaac Barchas	—	SELL	201.050K	$21.85	$4.4M
Jun 25, 2026	Robert Lechleider	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$14.29	$612K
Jun 15, 2026	Max Rosett	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$9.64	$1.0M
Jun 5, 2026	JACQUES JEAN BIENAIME	—	p / s	—	$19.43	$440
May 15, 2026	JACQUES JEAN BIENAIME	—	BUY	5.000K	$20.70	$104K